Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2007-07-10
2007-07-10
Campell, Bruce R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C514S04400A, C424S228100, C424S185100, C424S189100
Reexamination Certificate
active
10817591
ABSTRACT:
Compositions and methods for enhancing the effect of vaccines in animals, such as domestic, sport, or pet species, and humans are disclosed. More particularly, vaccine compositions comprising ribavirin and an antigen, preferably an antigen that has an epitope present in Hepatitis C virus (HCV), are disclosed for use in treating and preventing disease, preferably HCV infection.
REFERENCES:
patent: 4215051 (1980-07-01), Schroeder et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4486530 (1984-12-01), David et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4818540 (1989-04-01), Chien et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 4950647 (1990-08-01), Robins et al.
patent: 4965188 (1990-10-01), Mullis
patent: 5143854 (1992-09-01), Pirrung et al.
patent: 5290678 (1994-03-01), Jackowski
patent: 5322770 (1994-06-01), Gelfand
patent: 5350671 (1994-09-01), Houghton et al.
patent: 5371017 (1994-12-01), Houghton et al.
patent: 5372928 (1994-12-01), Miyamura et al.
patent: 5412087 (1995-05-01), McGall et al.
patent: 5585258 (1996-12-01), Houghton et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5597691 (1997-01-01), Houghton et al.
patent: 5604105 (1997-02-01), Jackowski
patent: 5670152 (1997-09-01), Weiner et al.
patent: 5670153 (1997-09-01), Weiner et al.
patent: 5679342 (1997-10-01), Houghton et al.
patent: 5683864 (1997-11-01), Houghton et al.
patent: 5698390 (1997-12-01), Houghton et al.
patent: 5710008 (1998-01-01), Jackowski
patent: 5712087 (1998-01-01), Houghton et al.
patent: 5712088 (1998-01-01), Houghton et al.
patent: 5712145 (1998-01-01), Houghton et al.
patent: 5714596 (1998-02-01), Houghton et al.
patent: 5728520 (1998-03-01), Weiner et al.
patent: 5744358 (1998-04-01), Jackowski
patent: 5747274 (1998-05-01), Jackowski
patent: 5756312 (1998-05-01), Weiner et al.
patent: 5766845 (1998-06-01), Weiner et al.
patent: 5767097 (1998-06-01), Tam
patent: 5847101 (1998-12-01), Okayama et al.
patent: 5856437 (1999-01-01), Miyamura et al.
patent: 5863719 (1999-01-01), Houghton et al.
patent: 5871903 (1999-02-01), Miyamura et al.
patent: 5879904 (1999-03-01), Brechot et al.
patent: 5885799 (1999-03-01), Houghton et al.
patent: 5932556 (1999-08-01), Tam et al.
patent: 5942234 (1999-08-01), Ralston et al.
patent: 5959092 (1999-09-01), Miyamura et al.
patent: 5968775 (1999-10-01), Houghton et al.
patent: 5989905 (1999-11-01), Houghton et al.
patent: 6027729 (2000-02-01), Houghton et al.
patent: 6056961 (2000-05-01), Lavie et al.
patent: 6060068 (2000-05-01), Doyle et al.
patent: 6063380 (2000-05-01), Chedid et al.
patent: 6063772 (2000-05-01), Tam
patent: 6071693 (2000-06-01), Cha et al.
patent: 6074816 (2000-06-01), Houghton et al.
patent: 6074846 (2000-06-01), Ralston et al.
patent: 6074852 (2000-06-01), Ralston et al.
patent: 6096541 (2000-08-01), Houghton et al.
patent: 6130326 (2000-10-01), Ramasamy et al.
patent: 6150087 (2000-11-01), Chien
patent: 6150337 (2000-11-01), Tam
patent: 6153421 (2000-11-01), Yanagi et al.
patent: 6171782 (2001-01-01), Houghton et al.
patent: 6190864 (2001-02-01), Cha et al.
patent: 6194140 (2001-02-01), Houghton et al.
patent: 6214583 (2001-04-01), Cha et al.
patent: 6235888 (2001-05-01), Pachuk et al.
patent: 6274148 (2001-08-01), Ralston et al.
patent: 6297370 (2001-10-01), Cha et al.
patent: 6303292 (2001-10-01), Weiner et al.
patent: 6312889 (2001-11-01), Houghton et al.
patent: 6514731 (2003-02-01), Valenzuela et al.
patent: 6541011 (2003-04-01), Punnonen et al.
patent: 6555114 (2003-04-01), Leroux-Roels et al.
patent: 6653125 (2003-11-01), Donnelly et al.
patent: 2002/0004048 (2002-01-01), Ralston et al.
patent: 2002/0165172 (2002-11-01), Sallberg et al.
patent: 2002/0183508 (2002-12-01), Maertens et al.
patent: 2002/0187945 (2002-12-01), Tam
patent: 2003/0007977 (2003-01-01), Wheeler et al.
patent: 2003/0008274 (2003-01-01), Maertens et al.
patent: 2003/0032005 (2003-02-01), Maertens et al.
patent: 2003/0044774 (2003-03-01), Valenzuela et al.
patent: 2003/0064360 (2003-04-01), Maertens et al.
patent: 2004/0092730 (2004-05-01), Sallberg
patent: 0 388 232 (1990-09-01), None
patent: 0 414 475 (1991-02-01), None
patent: 0 450 931 (1996-06-01), None
patent: 0 543 924 (1997-06-01), None
patent: 0 842 947 (1998-05-01), None
patent: 0 693 687 (1999-07-01), None
patent: 0 556 292 (1999-12-01), None
patent: 1 034 785 (2000-09-01), None
patent: 0 318 216 (2001-08-01), None
patent: 0 398 748 (2002-01-01), None
patent: WO 90/15070 (1990-12-01), None
patent: WO 91/15575 (1991-10-01), None
patent: WO 92/10092 (1992-06-01), None
patent: WO 92/19743 (1992-11-01), None
patent: WO 93/00365 (1993-01-01), None
patent: WO 93/06126 (1993-04-01), None
patent: WO 94/11530 (1994-05-01), None
patent: WO 94/12305 (1994-06-01), None
patent: WO 94/16737 (1994-08-01), None
patent: WO 95/11995 (1995-05-01), None
patent: WO 96/09805 (1996-04-01), None
patent: WO 96/28162 (1996-09-01), None
patent: WO 96/33739 (1996-10-01), None
patent: WO 97/12043 (1997-04-01), None
patent: WO 97/26883 (1997-07-01), None
patent: WO 97/29212 (1997-08-01), None
patent: WO 97/47358 (1997-12-01), None
patent: WO 98/16184 (1998-04-01), None
patent: WO 98/16186 (1998-04-01), None
patent: WO 98/30223 (1998-07-01), None
patent: WO 98/34640 (1998-08-01), None
patent: WO 98/37180 (1998-08-01), None
patent: WO 99/04008 (1999-01-01), None
patent: WO 99/28482 (1999-06-01), None
patent: WO 00/44388 (2000-08-01), None
patent: WO 01/38360 (2001-05-01), None
patent: WO 01/96875 (2001-12-01), None
patent: WO 02/13855 (2002-02-01), None
patent: WO 02/14362 (2002-02-01), None
patent: WO 03/031588 (2003-04-01), None
Encke et al. J. Immunol. 1998, vol. 161, pp. 4917-4923.
Rudikoff et al. Immunology 1982, vol. 79, pp. 1979-1983.
Hulgren et al. J. Gene. Virol. 1998, vol. 79, pp. 2381-2391.
Andre et al., “Increased Immune Response Elicited by DNA Vaccination with a Synthetic gp120 Sequence with Optimized Codon Usage,” Journal of Virology, 72(2):1497-1503(1998).
U.S. Appl. No. 08/008,342, filed Jan. 26, 1993, Weiner et al.
U.S. Appl. No. 08/029,336, filed Mar. 11, 1993, Weiner et al.
U.S. Appl. No. 08/125,012, filed Sep. 21, 1993, Weiner et al.
U.S. Appl. No. 08/221,579, filed Apr. 1, 1994, Carrano et al.
Database Genbank [Online] Dec. 2, 1994, retrieved from NCBI Database accession No. IO6434, XP002278035.
Database Registry [Online] No. 511600-20-7, XP02278058 abstract & WO 03/031588A, Apr. 17, 2003, Seq ID No. 1, 10 and 11 Claims.
Encke et al., “DNA Vaccines,” Intervirology, 42:117-124, (1999).
Forns et al., “Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resalving or persistent infection in chimpanzees,” PNAS, vol. 97, No. 24, pp. 13318-113323, (2000).
Hahm et al., “NS3-4A of Hepatitis C Virus is a Chymotrypsin-Like Protease,” Journal of Virology, The American Society for Microbiology, 69(4): 2534-2539 (1995).
Kumar et al., “Hepatitis C virus genomic RNA for polyprotein gene,” Journal of Hepatology, 7:459-465 (2000).
Lazdina et al., “Humoral and CD4* T helper (th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes TH 1-like responses more effectively as a DNA-Based immunogen than as a recombinant protein,” Journal of General Virology, 82:1299-1308 (2001).
Lohmann et al., “Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line,” Science, 285:110-113, (1999).
NCBI, Genbank, M32084. Hepatitis C Virus . . . [Gi:32987] Aug. 02, 1993.
AASLD Abstracts 940, “Hepatitis C Virus NS5A Sequence Configuration does not Predict Response to Induction Interferon Plus Ribavirin,” Hepatology, p. 394A, (2000).
Abrignani et al., “Perspectives for a vaccine against hepatitis C virus,” Journal of Hepatology, 31: (suppl. 1):259-263 (1999).
Bartenschlager et al., “Substrate Determinants for Cleavage in cis and in trans by the Hapatitis C Virus NS3 Proteinase,”Journa
Hultgren Catharina
Sällberg Matti
Campell Bruce R.
Knobbe Martens Olson & Bear LLP
Li Bao Qun
Tripep AB
LandOfFree
Vaccines containing ribavirin and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines containing ribavirin and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines containing ribavirin and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3746584